We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Mgc Pharmaceuticals Limited | LSE:MXC | London | Ordinary Share | AU000000MXC6 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 22.00 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Drug & Proprietary Stores | 4.16M | -20.82M | -0.4749 | -0.84 | 17.54M |
| Date | Time | Source | Headline |
|---|---|---|---|
| 03/4/2024 | 07:30 | UK RNS | London Stock Exchange Notice Suspension - MGC Pharmaceuticals Limited |
| 02/4/2024 | 15:40 | UK RNS | MGC Pharmaceuticals Limited Change of name to Argent BioPharma Limited |
| 28/3/2024 | 09:12 | UK RNS | MGC Pharmaceuticals Limited PDMR Notification |
| 28/3/2024 | 09:07 | UK RNS | MGC Pharmaceuticals Limited Refinancing of Convertible Securities Agreement |
| 18/3/2024 | 08:23 | UK RNS | MGC Pharmaceuticals Limited Results of General Meeting |
| 29/2/2024 | 17:00 | ALNC |  EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout |
| 29/2/2024 | 09:36 | UK RNS | MGC Pharmaceuticals Limited Half-year Report |
| 19/2/2024 | 16:00 | UK RNS | MGC Pharmaceuticals Limited Update - Application for Admission to Trading |
| 13/2/2024 | 11:54 | ALNC | IN BRIEF: MGC Pharmaceuticals proposes name change to Argent Biopharma |
| 13/2/2024 | 10:00 | UK RNS | MGC Pharmaceuticals Limited Dispatch of General Meeting Documents |
1 Year Mgc Pharmaceuticals Chart |
Intraday Mgc Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
